In one meta-analysis of comparing three drugs – Fluvoxamine, Paxlovid and Molnupiravir, only Fluvoxamine reflected the most cases of deaths (and in all cases heart failures!) https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2034936 A study in December 2021 already highlighted that Fluvoxamine is not effective in preventing disease severity. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745642/ BA.2 and its emerging variants are adapt at replicating very fast in the … Leggi tutto COVID-19: Fluvoxamine is not effective in preventing disease severity and increase the risk of heart failure